Home » Topics » Disease categories and therapies » Inflammatory

Inflammatory
RSS

Universite Laval patents IL-6 expression inhibitors

Jan. 8, 2019

Galapagos initiates phase I trial with GLPG-3312

Jan. 7, 2019

Resolvin receptor analogues limit inflammation

Dec. 18, 2018

Anti-inflammatory compositions presented by House Wellness Foods, House Foods Group

Nov. 29, 2018

New anti-inflammation target has similarities, and differences, to PARP

Nov. 23, 2018

New path to RAS activation discovered

Nov. 23, 2018

The point of disorder

Nov. 21, 2018

ILDONG Pharmaceutical discovers farnesoid X receptor agonists

Nov. 2, 2018

Eiger's phase II study of ubenimex in lower leg lymphedema does not meet endpoints

Oct. 17, 2018

SHIP2 is key in FGF signaling and necessary for the maintenance of FGF-mediated ERK activation

Oct. 15, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...
AI drug developer Insilico to raise $292 million in Hong Kong IPO
BioWorld
Insilico Medicine Inc. plans to raise HK$2.27 billion (US$292 million) in its IPO on the Hong Kong Securities Exchange to advance its clinical pipeline and invest...